Emma Bergfelt

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The introduction of minimal residual disease (MRD) monitoring, in the Swedish national guidelines for acute lymphoblastic leukaemia, was evaluated in 35 patients aged 46-79 years (median 61), who(More)
  • 1